À¯·´ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå : Medtech 360
Interventional Oncology Devices | Medtech 360 | Market Insights | Europe
»óǰÄÚµå : 1509825
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,741,000
Web Access and PDF Download (Corporate Use License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

À¯·´ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀåÀº ¾Ï ¹ßº´·ü ¹× À¯º´·ü Áõ°¡, ¼ö¼ú ´ëºñ ÀýÁ¦¼ú ¹× »öÀü¼úÀÇ ºñ¿ë È¿À²¼º, °³¼±µÈ »óȯ Á¦µµ, °¡À̵å¶óÀÎ º¯°æ, Çõ½ÅÀûÀÎ Á¦Ç° Ãâ½Ã, ÃÖ¼Òħ½À ¼ö¼úÀÇ Àαâ Áõ°¡, ÁßÀçÀû Á¾¾çÇÐ ½Ã¼úÀÇ ÀÇ»çµéÀÇ Ä§Åõ µîÀ» ¹è°æÀ¸·Î 2033³â±îÁö ¿Ï¸¸ÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÇÏÁö¸¸, ÀÓ»ó µ¥ÀÌÅÍÀÇ ºÒÀÏÄ¡, Ä¡¿­ÇÑ °¡°Ý °æÀï, ÀÌ Áö¿ªÀÇ Áö¼ÓÀûÀÎ ºñ¿ë Á¦¾à µîÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â À¯·´ ±¹°¡ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ¿Í ºÐ¼®(2019-2033³â)À» Á¦°øÇÕ´Ï´Ù.

ÀýÁ¦ ÀåÄ¡ ½ÃÀå¿¡¼­´Â ¸¶ÀÌÅ©·ÎÆÄ ÀýÁ¦¼úÀÌ Áö¹èÀûÀÌÁö¸¸, »õ·Î¿î ±â¼úÀÌ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÀýÁ¦¿ä¹ýÀº °£¾Ï, ½ÅÀå¾Ï, Æó¾ÏÀÇ ÀûÀÀÁõÀ¸·Î ¾ÕÀ¸·Îµµ °è¼Ó ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù.

DEB¿Í ¹æ»ç¼± »öÀü±¸ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

À¯·´

°³¿ä

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä º¸°í¼­ ¾÷µ¥ÀÌÆ® ÀÌ·Â

ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå

ÀýÁ¦ ±â±â ½ÃÀå

»öÀü ±â±â ½ÃÀå

¾×¼¼¼­¸® µð¹ÙÀ̽º ½ÃÀå

ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and embolization devices compared to surgery, improved reimbursement, changing guidelines, launch of innovative products, increasing popularity of minimally invasive surgeries, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data, increasing-price competition, and ongoing cost constraints in the region.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019 to 2033.

The ablation device market is dominated by microwave ablation; however, new technologies are increasingly being used.

Ablation therapy procedures will continue to grow for the liver, kidney, and lung cancer indications.

DEBs and radioembolization spheres are seeing increasing adoption.

Table of Contents

Europe

Abstract

Executive Summary

Key Report Updates

Interventional Oncology Device Market

Ablation Device Market

Embolization Device Market

Accessory Device Market

Appendix

Tables and Figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â